This educational program consists of three presentations on the role of SGLT2i in tackling cardiorenal risk in diabetes.

This course consists of the following:

• Introduction on tackling cardiorenal risk in diabetes - Prof. Melanie Davies, MD – Leicester, UK
• SGLT2i: Overview of recent trials and guideline recommendations - Prof. Nikolaus Marx, MD – Aachen, Germany
• Dialogue on how to overcome clinical inertia with regard to SGLT2i - Prof. Melanie Davies, MD – Leicester, UK and prof. Nikolaus Marx, MD – Aachen, Germany

How to obtain your CME certificate

• Watch the three 3 lectures, and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Describe the overlap in T2DM, CKD and CVD (including HF)
• Recall findings from SGLT2i trials and recommendations from the ESC guidelines and the ADA-EASD consensus report
• Describe trends of SGLT2i prescription in T2DM patients with CVD
• Discuss tips for safe and practical initiation of SGLT2i therapy

Expert faculty

• Prof. Melanie Davies, MD – Leicester, UK
• Prof. Nikolaus Marx, MD – Aachen, Germany

Target audience

This educational activity is designed for all healthcare professionals with an interest in management of patients with diabetes and cardiorenal risk risk. 

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by unrestricted educational grants from Boehringer Ingelheim/Lilly.

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.